{"id":18042,"date":"2026-01-12T20:52:50","date_gmt":"2026-01-13T00:52:50","guid":{"rendered":"https:\/\/divulguems.com.br\/?p=18042"},"modified":"2026-01-12T20:52:50","modified_gmt":"2026-01-13T00:52:50","slug":"anvisa-aprova-novo-farmaco-com-injecao-semestral-para-prevencao-do-hiv","status":"publish","type":"post","link":"https:\/\/divulguems.com.br\/?p=18042","title":{"rendered":"Anvisa aprova novo f\u00e1rmaco com inje\u00e7\u00e3o semestral para preven\u00e7\u00e3o do HIV"},"content":{"rendered":"<\/p>\n<p><a class=\"\" href=\"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-01\/anvisa-aprova-novo-farmaco-com-injecao-semestral-para-prevencao-do-hiv\"><br \/>\n                    <img decoding=\"async\" src=\"https:\/\/cdn.jsdelivr.net\/gh\/sergiosdlima\/assets-ebc@1.0.0\/abr\/assets\/images\/logo-agenciabrasil.svg\" alt=\"Logo Ag\u00eancia Brasil\"><br \/>\n\t\t\t\t<\/a><\/p>\n<p>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou nesta segunda-feira (12) o uso do medicamento Sunlenca (lenacapavir) para preven\u00e7\u00e3o do HIV-1,\u00a0como profilaxia pr\u00e9-exposi\u00e7\u00e3o (PrEP). O f\u00e1rmaco tem alta efic\u00e1cia contra o v\u00edrus e, al\u00e9m da apresenta\u00e7\u00e3o em compromido, para uso oral,\u00a0est\u00e1 dispon\u00edvel como inje\u00e7\u00e3o subcut\u00e2nea que s\u00f3 precisa ser\u00a0administrada a cada seis meses, o que facilita a ades\u00e3o.<img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.png?id=1674809&#038;o=rss\"><img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.gif?id=1674809&#038;o=rss\"><\/p>\n<p><strong>A indica\u00e7\u00e3o \u00e9 destinada a adultos e adolescentes a partir de 12 anos, com peso m\u00ednimo de 35 kg, que estejam sob risco de contrair o v\u00edrus.<\/strong> Antes de iniciar o tratamento, \u00e9 obrigat\u00f3rio realizar teste com resultado negativo para HIV-1.<\/p>\n<\/p>\n<h3>Not\u00edcias relacionadas:<\/h3>\n<ul>\n<li><a href=\"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2025-07\/oms-recomenda-uso-de-lenacapavir-para-prevenir-infecao-por-hiv\">OMS recomenda uso de lenacapavir para prevenir infe\u00e7\u00e3o por HIV.<\/a><\/li>\n<li><a href=\"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-01\/cobertura-de-testagem-para-hiv-cresce-47-em-comunidades-indigenas\">Cobertura de testagem para HIV cresce 47% em comunidades ind\u00edgenas.<\/a><\/li>\n<li><a href=\"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2025-12\/oms-reconhece-o-fim-da-transmissao-do-hiv-de-mae-para-filho-no-pais\">OMS reconhece o fim da transmiss\u00e3o do HIV de m\u00e3e para filho no pa\u00eds.<\/a><\/li>\n<\/ul>\n<p>Os estudos cl\u00ednicos apresentados demonstraram 100% de efic\u00e1cia do Sunlenca na redu\u00e7\u00e3o da incid\u00eancia de HIV-1 em mulheres cisg\u00eanero; al\u00e9m de 96% de efic\u00e1cia em compara\u00e7\u00e3o com a incid\u00eancia de HIV de base e 89% superior \u00e0 PrEP oral di\u00e1ria.<\/p>\n<p><strong>O regime de inje\u00e7\u00f5es semestrais\u00a0mostrou boa ades\u00e3o e persist\u00eancia, superando desafios comuns em esquemas di\u00e1rios, informou a Anvisa, por meio de sua assessoria de imprensa.<\/strong><\/p>\n<p>De acordo com a Anvisa, a Sunlenca \u00e9 um antirretroviral inovador composto por lenacapavir, f\u00e1rmaco de primeira classe que atua inibindo m\u00faltiplos est\u00e1gios da fun\u00e7\u00e3o do caps\u00eddeo do HIV-1.<\/p>\n<p>Essa a\u00e7\u00e3o impede a replica\u00e7\u00e3o do v\u00edrus, tornando-o incapaz de sustentar a transcri\u00e7\u00e3o reversa, processo em necess\u00e1rio para que use as c\u00e9lulas do hospedeiro para se multiplicar.<\/p>\n<p>A ag\u00eancia advertiu que, embora o registro tenha sido concedido, o medicamento depende ainda da defini\u00e7\u00e3o do pre\u00e7o m\u00e1ximo pela C\u00e2mara de Regula\u00e7\u00e3o do Mercado de Medicamentos (CMED).<\/p>\n<p><strong>J\u00e1 sua disponibiliza\u00e7\u00e3o no Sistema \u00danico de Sa\u00fade (SUS) ser\u00e1 avaliada pela Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec) e pelo Minist\u00e9rio da Sa\u00fade.<\/strong><\/p>\n<h2>Preven\u00e7\u00e3o<\/h2>\n<p>A profilaxia pr\u00e9-exposi\u00e7\u00e3o (PrEP) \u00e9 uma estrat\u00e9gia essencial para prevenir a infec\u00e7\u00e3o pelo HIV. Ela envolve o uso de medicamentos antirretrovirais por pessoas que n\u00e3o t\u00eam o v\u00edrus, mas est\u00e3o sob risco de contrair a doen\u00e7a, reduzindo significativamente as chances de transmiss\u00e3o.<\/p>\n<p><strong>A PrEP faz parte da chamada \u201cpreven\u00e7\u00e3o combinada\u201d, que inclui outras medidas, como testagem regular para HIV, uso de preservativos, tratamento antirretroviral (TARV), profilaxia p\u00f3s-exposi\u00e7\u00e3o (PEP) e cuidados espec\u00edficos para gestantes soropositivas<\/strong>, esclareceu a Ag\u00eancia.<\/p>\n<p>O lenacapavir passou a ser recomendado pela Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS) em julho de 2025 como op\u00e7\u00e3o adicional para PrEP, classificando-o como a melhor alternativa ap\u00f3s uma vacina, recurso que ainda n\u00e3o est\u00e1 dispon\u00edvel no caso da preven\u00e7\u00e3o do HIV.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou nesta segunda-feira (12) o uso do medicamento Sunlenca (lenacapavir) para preven\u00e7\u00e3o do HIV-1,\u00a0como profilaxia pr\u00e9-exposi\u00e7\u00e3o (PrEP). O f\u00e1rmaco tem alta efic\u00e1cia contra o v\u00edrus e, al\u00e9m da apresenta\u00e7\u00e3o em compromido, para uso oral,\u00a0est\u00e1 dispon\u00edvel como inje\u00e7\u00e3o subcut\u00e2nea que s\u00f3 precisa ser\u00a0administrada a cada seis meses, o que [&hellip;]<\/p>\n","protected":false},"author":554,"featured_media":18043,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[11],"tags":[],"class_list":["post-18042","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saude-e-bem-estar"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Anvisa aprova novo f\u00e1rmaco com inje\u00e7\u00e3o semestral para preven\u00e7\u00e3o do HIV - Divulgue MS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/divulguems.com.br\/?p=18042\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa aprova novo f\u00e1rmaco com inje\u00e7\u00e3o semestral para preven\u00e7\u00e3o do HIV\" \/>\n<meta property=\"og:description\" content=\"A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou nesta segunda-feira (12) o uso do medicamento Sunlenca (lenacapavir) para preven\u00e7\u00e3o do HIV-1,\u00a0como profilaxia pr\u00e9-exposi\u00e7\u00e3o (PrEP). O f\u00e1rmaco tem alta efic\u00e1cia contra o v\u00edrus e, al\u00e9m da apresenta\u00e7\u00e3o em compromido, para uso oral,\u00a0est\u00e1 dispon\u00edvel como inje\u00e7\u00e3o subcut\u00e2nea que s\u00f3 precisa ser\u00a0administrada a cada seis meses, o que [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/divulguems.com.br\/?p=18042\" \/>\n<meta property=\"og:site_name\" content=\"Divulgue MS\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/portalinfocobrasil\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-13T00:52:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cdn.jsdelivr.net\/gh\/sergiosdlima\/assets-ebc@1.0.0\/abr\/assets\/images\/logo-agenciabrasil.svg\" \/>\n<meta name=\"author\" content=\"Alana Gandra - Reporter da Agencia Brasil\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alana Gandra - Reporter da Agencia Brasil\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=18042#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=18042\"},\"author\":{\"name\":\"Alana Gandra - Reporter da Agencia Brasil\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#\\\/schema\\\/person\\\/764a3b32925a05a6c1424315aae4c438\"},\"headline\":\"Anvisa aprova novo f\u00e1rmaco com inje\u00e7\u00e3o semestral para preven\u00e7\u00e3o do HIV\",\"datePublished\":\"2026-01-13T00:52:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=18042\"},\"wordCount\":523,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=18042#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/divulguems.com.br\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/18042-anvisa-aprova-novo-farmaco-com-injecao-semestral-para-prevencao-do-hiv.jpeg\",\"articleSection\":[\"Sa\u00fade e Bem-Estar\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/divulguems.com.br\\\/?p=18042#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=18042\",\"url\":\"https:\\\/\\\/divulguems.com.br\\\/?p=18042\",\"name\":\"Anvisa aprova novo f\u00e1rmaco com inje\u00e7\u00e3o semestral para preven\u00e7\u00e3o do HIV - Divulgue MS\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=18042#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=18042#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/divulguems.com.br\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/18042-anvisa-aprova-novo-farmaco-com-injecao-semestral-para-prevencao-do-hiv.jpeg\",\"datePublished\":\"2026-01-13T00:52:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=18042#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/divulguems.com.br\\\/?p=18042\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=18042#primaryimage\",\"url\":\"https:\\\/\\\/divulguems.com.br\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/18042-anvisa-aprova-novo-farmaco-com-injecao-semestral-para-prevencao-do-hiv.jpeg\",\"contentUrl\":\"https:\\\/\\\/divulguems.com.br\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/18042-anvisa-aprova-novo-farmaco-com-injecao-semestral-para-prevencao-do-hiv.jpeg\",\"width\":1600,\"height\":800,\"caption\":\"Anvisa aprova novo f\u00e1rmaco com inje\u00e7\u00e3o semestral para preven\u00e7\u00e3o do HIV\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=18042#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/divulguems.com.br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa aprova novo f\u00e1rmaco com inje\u00e7\u00e3o semestral para preven\u00e7\u00e3o do HIV\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#website\",\"url\":\"https:\\\/\\\/divulguems.com.br\\\/\",\"name\":\"Portal Infoco Brasil\",\"description\":\"L\u00edder de audi\u00eancia.\",\"publisher\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/divulguems.com.br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#organization\",\"name\":\"Portal Infoco Brasil\",\"url\":\"https:\\\/\\\/divulguems.com.br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/divulguems.com.br\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/LOGO-PNG-AZUL.png\",\"contentUrl\":\"https:\\\/\\\/divulguems.com.br\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/LOGO-PNG-AZUL.png\",\"width\":1166,\"height\":475,\"caption\":\"Portal Infoco Brasil\"},\"image\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/portalinfocobrasil\",\"https:\\\/\\\/www.instagram.com\\\/portalinfocobrasil\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#\\\/schema\\\/person\\\/764a3b32925a05a6c1424315aae4c438\",\"name\":\"Alana Gandra - Reporter da Agencia Brasil\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dda9d328ebcbee957951747ed0c3a3614f9c24c30d8ed2f6d7d50e970f81542a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dda9d328ebcbee957951747ed0c3a3614f9c24c30d8ed2f6d7d50e970f81542a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dda9d328ebcbee957951747ed0c3a3614f9c24c30d8ed2f6d7d50e970f81542a?s=96&d=mm&r=g\",\"caption\":\"Alana Gandra - Reporter da Agencia Brasil\"},\"url\":\"https:\\\/\\\/divulguems.com.br\\\/?author=554\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Anvisa aprova novo f\u00e1rmaco com inje\u00e7\u00e3o semestral para preven\u00e7\u00e3o do HIV - Divulgue MS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/divulguems.com.br\/?p=18042","og_locale":"pt_BR","og_type":"article","og_title":"Anvisa aprova novo f\u00e1rmaco com inje\u00e7\u00e3o semestral para preven\u00e7\u00e3o do HIV","og_description":"A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou nesta segunda-feira (12) o uso do medicamento Sunlenca (lenacapavir) para preven\u00e7\u00e3o do HIV-1,\u00a0como profilaxia pr\u00e9-exposi\u00e7\u00e3o (PrEP). O f\u00e1rmaco tem alta efic\u00e1cia contra o v\u00edrus e, al\u00e9m da apresenta\u00e7\u00e3o em compromido, para uso oral,\u00a0est\u00e1 dispon\u00edvel como inje\u00e7\u00e3o subcut\u00e2nea que s\u00f3 precisa ser\u00a0administrada a cada seis meses, o que [&hellip;]","og_url":"https:\/\/divulguems.com.br\/?p=18042","og_site_name":"Divulgue MS","article_publisher":"https:\/\/www.facebook.com\/portalinfocobrasil","article_published_time":"2026-01-13T00:52:50+00:00","og_image":[{"url":"https:\/\/cdn.jsdelivr.net\/gh\/sergiosdlima\/assets-ebc@1.0.0\/abr\/assets\/images\/logo-agenciabrasil.svg","type":"","width":"","height":""}],"author":"Alana Gandra - Reporter da Agencia Brasil","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Alana Gandra - Reporter da Agencia Brasil","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/divulguems.com.br\/?p=18042#article","isPartOf":{"@id":"https:\/\/divulguems.com.br\/?p=18042"},"author":{"name":"Alana Gandra - Reporter da Agencia Brasil","@id":"https:\/\/divulguems.com.br\/#\/schema\/person\/764a3b32925a05a6c1424315aae4c438"},"headline":"Anvisa aprova novo f\u00e1rmaco com inje\u00e7\u00e3o semestral para preven\u00e7\u00e3o do HIV","datePublished":"2026-01-13T00:52:50+00:00","mainEntityOfPage":{"@id":"https:\/\/divulguems.com.br\/?p=18042"},"wordCount":523,"commentCount":0,"publisher":{"@id":"https:\/\/divulguems.com.br\/#organization"},"image":{"@id":"https:\/\/divulguems.com.br\/?p=18042#primaryimage"},"thumbnailUrl":"https:\/\/divulguems.com.br\/wp-content\/uploads\/2026\/01\/18042-anvisa-aprova-novo-farmaco-com-injecao-semestral-para-prevencao-do-hiv.jpeg","articleSection":["Sa\u00fade e Bem-Estar"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/divulguems.com.br\/?p=18042#respond"]}]},{"@type":"WebPage","@id":"https:\/\/divulguems.com.br\/?p=18042","url":"https:\/\/divulguems.com.br\/?p=18042","name":"Anvisa aprova novo f\u00e1rmaco com inje\u00e7\u00e3o semestral para preven\u00e7\u00e3o do HIV - Divulgue MS","isPartOf":{"@id":"https:\/\/divulguems.com.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/divulguems.com.br\/?p=18042#primaryimage"},"image":{"@id":"https:\/\/divulguems.com.br\/?p=18042#primaryimage"},"thumbnailUrl":"https:\/\/divulguems.com.br\/wp-content\/uploads\/2026\/01\/18042-anvisa-aprova-novo-farmaco-com-injecao-semestral-para-prevencao-do-hiv.jpeg","datePublished":"2026-01-13T00:52:50+00:00","breadcrumb":{"@id":"https:\/\/divulguems.com.br\/?p=18042#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/divulguems.com.br\/?p=18042"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/divulguems.com.br\/?p=18042#primaryimage","url":"https:\/\/divulguems.com.br\/wp-content\/uploads\/2026\/01\/18042-anvisa-aprova-novo-farmaco-com-injecao-semestral-para-prevencao-do-hiv.jpeg","contentUrl":"https:\/\/divulguems.com.br\/wp-content\/uploads\/2026\/01\/18042-anvisa-aprova-novo-farmaco-com-injecao-semestral-para-prevencao-do-hiv.jpeg","width":1600,"height":800,"caption":"Anvisa aprova novo f\u00e1rmaco com inje\u00e7\u00e3o semestral para preven\u00e7\u00e3o do HIV"},{"@type":"BreadcrumbList","@id":"https:\/\/divulguems.com.br\/?p=18042#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/divulguems.com.br\/"},{"@type":"ListItem","position":2,"name":"Anvisa aprova novo f\u00e1rmaco com inje\u00e7\u00e3o semestral para preven\u00e7\u00e3o do HIV"}]},{"@type":"WebSite","@id":"https:\/\/divulguems.com.br\/#website","url":"https:\/\/divulguems.com.br\/","name":"Portal Infoco Brasil","description":"L\u00edder de audi\u00eancia.","publisher":{"@id":"https:\/\/divulguems.com.br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/divulguems.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/divulguems.com.br\/#organization","name":"Portal Infoco Brasil","url":"https:\/\/divulguems.com.br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/divulguems.com.br\/#\/schema\/logo\/image\/","url":"https:\/\/divulguems.com.br\/wp-content\/uploads\/2025\/04\/LOGO-PNG-AZUL.png","contentUrl":"https:\/\/divulguems.com.br\/wp-content\/uploads\/2025\/04\/LOGO-PNG-AZUL.png","width":1166,"height":475,"caption":"Portal Infoco Brasil"},"image":{"@id":"https:\/\/divulguems.com.br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/portalinfocobrasil","https:\/\/www.instagram.com\/portalinfocobrasil"]},{"@type":"Person","@id":"https:\/\/divulguems.com.br\/#\/schema\/person\/764a3b32925a05a6c1424315aae4c438","name":"Alana Gandra - Reporter da Agencia Brasil","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/dda9d328ebcbee957951747ed0c3a3614f9c24c30d8ed2f6d7d50e970f81542a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/dda9d328ebcbee957951747ed0c3a3614f9c24c30d8ed2f6d7d50e970f81542a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/dda9d328ebcbee957951747ed0c3a3614f9c24c30d8ed2f6d7d50e970f81542a?s=96&d=mm&r=g","caption":"Alana Gandra - Reporter da Agencia Brasil"},"url":"https:\/\/divulguems.com.br\/?author=554"}]}},"_links":{"self":[{"href":"https:\/\/divulguems.com.br\/index.php?rest_route=\/wp\/v2\/posts\/18042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/divulguems.com.br\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/divulguems.com.br\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/divulguems.com.br\/index.php?rest_route=\/wp\/v2\/users\/554"}],"replies":[{"embeddable":true,"href":"https:\/\/divulguems.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18042"}],"version-history":[{"count":0,"href":"https:\/\/divulguems.com.br\/index.php?rest_route=\/wp\/v2\/posts\/18042\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/divulguems.com.br\/index.php?rest_route=\/wp\/v2\/media\/18043"}],"wp:attachment":[{"href":"https:\/\/divulguems.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18042"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/divulguems.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18042"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/divulguems.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}